SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-002713
Filing Date
2021-03-10
Accepted
2021-03-10 16:24:30
Documents
13
Period of Report
2021-03-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xncr-20210305x8k.htm   iXBRL 8-K 46347
2 EX-10.1 xncr-20210305xex10d1.htm EX-10.1 54582
  Complete submission text file 0001558370-21-002713.txt   232179

Data Files

Seq Description Document Type Size
3 EX-101.SCH xncr-20210305.xsd EX-101.SCH 2975
4 EX-101.LAB xncr-20210305_lab.xml EX-101.LAB 15410
5 EX-101.PRE xncr-20210305_pre.xml EX-101.PRE 9959
6 EXTRACTED XBRL INSTANCE DOCUMENT xncr-20210305x8k_htm.xml XML 4622
Mailing Address 111 WEST LEMON AVE MONROVIA CA 91016
Business Address 111 WEST LEMON AVE MONROVIA CA 91016 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

IRS No.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36182 | Film No.: 21730033
SIC: 2834 Pharmaceutical Preparations